Use of antiepileptic medications in pregnancy in relation to risks of birth defects
about
The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature ReviewGenetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD)Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoringEpilepsy during pregnancy: focus on management strategiesA transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitorsBirth defects data from population-based birth defects surveillance programs in the United States, 2007 to 2011: highlighting orofacial clefts.Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsantsIsaacs' syndrome in pregnancyCongenital Malformations and Consequential Epidemiology.Proportion of neural tube defects attributable to known risk factors.Use of prescription medicines in Australian women of child-bearing age.Challenges in Studying Modifiable Risk Factors for Birth DefectsUse of topiramate in pregnancy and risk of oral clefts.2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The LifespanEnvironmental factors related to the occurrence of oral clefts in a Brazilian subpopulation.Increasing use of atypical antipsychotics and anticonvulsants during pregnancy.Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and HumansPrenatal and perinatal environmental influences on the human fetal and placental epigenome.Nongenetic risk factors and congenital heart defects.Treating epilepsy in pregnant women.Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.Bipolar Disorder in Pregnancy and Postpartum: Principles of Management.Neural tube closure: cellular, molecular and biomechanical mechanisms.Bayesian regression in SAS software.Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.Valproate prescriptions for nonepilepsy disorders in reproductive-age women.Associations between laterality of orofacial clefts and medical and academic outcomes.Antiepileptic drugs and pregnancy outcomes.
P2860
Q26741366-702520BA-A2E3-4A5E-AA4F-1A77A0ECD8BCQ26741618-44E3A1AB-9FBB-4A86-9F6F-D80F2821C217Q27027293-EDAD477D-0D0C-4128-A2A1-A9868BBB72C6Q28080299-8B1C3520-955E-4C57-B873-62AF38DE8355Q30662775-ACE77CF5-8336-414B-BBC2-A4A548380E35Q30870008-D8A09A52-0FB1-470B-8314-AF81DAAB9481Q34147151-FD4B69EC-B2BF-4441-8212-1054DB4066F8Q34329864-B0149346-E7F4-40C8-8088-48248A968E50Q35077898-BDFA18B7-EFC7-4928-AD6B-12AA2107B0F9Q35787018-8EC73FF4-AD99-41E3-9F3E-97E08D2E26C8Q35862755-6C7459C0-E64D-4898-800D-04FC026F6213Q35894122-50A8B4F0-25A0-4DD5-AE25-6219E27B444EQ36356810-080B572F-ADCF-438B-98C7-9015FBD99746Q37021068-E1059610-5096-4FA3-B92B-66CF721ECB49Q37045635-139E9554-29B9-4F94-A3EA-0C60AA056778Q37464232-EC988A2A-B2B8-452E-8571-18FD32FCE190Q37668913-DE5848B2-EC02-42A4-95B0-A1BACE256FAAQ38050688-5748591E-24DB-4DBE-9D32-FE4C89769726Q38130429-E97B31FB-AAEF-45E8-91A9-30FD458DB08DQ38194574-AE402411-6567-4095-9BC5-A4493E2F3E8AQ38319756-E27609E3-9AEE-4112-B194-4CA711A20B9DQ38701750-DE16FBE4-9F75-4306-BA5F-B19FC135D9B8Q39135434-D07071B1-0DAD-4B2A-B95C-621DF4928718Q43577395-DC219AF9-759F-4375-B647-59F92507FA3DQ53107393-50D857E6-BF70-467A-8BD6-4D57B1C2A2C4Q53109252-7494BBA7-59CD-4591-B52C-DF656D68715AQ53488600-1907F43F-E485-418B-98F6-336317D312B3Q55716842-247EDFC9-8538-4002-9E9E-9F03A0386087
P2860
Use of antiepileptic medications in pregnancy in relation to risks of birth defects
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Use of antiepileptic medications in pregnancy in relation to risks of birth defects
@en
type
label
Use of antiepileptic medications in pregnancy in relation to risks of birth defects
@en
prefLabel
Use of antiepileptic medications in pregnancy in relation to risks of birth defects
@en
P2093
P2860
P50
P1476
Use of antiepileptic medications in pregnancy in relation to risks of birth defects
@en
P2093
Jaclyn L F Bosco
Lewis B Holmes
Marlene T Anderka
National Birth Defects Prevention Study
Suzanne M Gilboa
P2860
P304
P356
10.1016/J.ANNEPIDEM.2011.08.002
P577
2011-11-01T00:00:00Z